OTC Markets OTCPK - Delayed Quote USD

GSK plc (GLAXF)

18.46

+1.14

+(6.58%)

At close: 11:39:40 AM EDT

Shingles Vaccine Appears to Lower Dementia Risk

Mounting evidence suggests that vaccination against the varicella zoster virus—which causes chickenpox in children and triggers shingles in adults—also protects the brain. Several recent studies suggest that the vaccines reduce the risk of dementia in older adults, but key questions remain, including: How the vaccines might work to stop or delay the condition, and whether the benefit is limited to people of a certain age. The vaccines studied, Zostavax and Shingrix, both appeared to offer protection.

The Wall Street Journal yesterday

GLAXF
+6.58%
GSK
Why vaccine makers aren't worried about Trump administration cuts

Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

Yahoo Finance yesterday

MRNA

MRK

SNY
Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks yesterday

NEO

GSK
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years

On Wednesday, the Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of respiratory syncytial virus (RSV) vaccines approved for adults 50-59 years of age at increased risk of RSV-associated lower respiratory tract disease (LRTD). In June 2024, ACIP postponed a vote on a recommendation for adults aged 50-59 at increased risk for RSV-LRTD until additional data becomes available. The update includes Pfizer Inc.’s (NYSE:PFE) Abrysvo (Respiratory Syncyt

Benzinga 7 days ago

GSK

PFE

MRNA
UK Becomes First Country To Authorize Blenrep In Two Combo Regimens

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE:GSK) Blenrep. Blenrep is approved for the treatment of adults with multiple myeloma in combination with bortezomib plus dexamethasone (BVd) in patients who have received at least one prior therapy, and in combination with pomalidomide plus dexamethasone (BPd) in patients who have received at least one prior therapy including lenalidomide. This U.K. regulatory authorization marks the first

Benzinga 7 days ago

GSK
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease

--76-week trial is evaluating the safety and efficacy of a progranulin-elevating candidate in slowing disease progression-- --Enrollment completed ahead of schedule-- SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced the completion of enrollment in PROGRESS-AD, a 76-week Phase 2 clinical trial evalu

GlobeNewswire 7 days ago

GLAXF
+6.58%
GSK

ALEC
AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices

PHILADELPHIA, April 16, 2025--AREXVY recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices

Business Wire 8 days ago

GLAXF
+6.58%
GSK
GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices

PHILADELPHIA, April 16, 2025--GSK’s 5-in-1 meningococcal vaccine PENMENVY receives positive recommendation from US Advisory Committee on Immunization Practices

Business Wire 8 days ago

GLAXF
+6.58%
GSK
GSK (LSE:GSK) Sees 6% Share Price Decline Over The Last Quarter

GSK (LSE:GSK) recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and the EMA's acceptance of an application for Nucala's expanded use. Despite these positive developments, the company's share price experienced a 6% decline over the last quarter. This movement occurred amid broader market volatility, where major indices faced notable declines, though recently improved following a pause on tariffs. GSK's earnings report revealed a decline...

Simply Wall St. 14 days ago

GLAXF
+6.58%
GSK
GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025

PHILADELPHIA, April 09, 2025--GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025

Business Wire 15 days ago

GLAXF
+6.58%
GSK
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca

The latest investor updates on stocks that are trending on Wednesday.

Yahoo Finance UK 15 days ago

DAL

GM

SVNDF
New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops

Researchers investigated whether the shingles (herpes zoster) vaccine can help prevent dementia. Previous studies suggest that certain herpes viruses may contribute to dementia, and vaccines might have immune benefits. The new research, published on ...

Benzinga 20 days ago

GSK
GSK resolves patent lawsuit against Pfizer over RSV vaccines

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent rights in its competing RSV shot Arexvy, according to a Thursday filing in Delaware federal court. GSK and Pfizer said in the filing that they would dismiss the case with prejudice, which means it cannot be refiled. GSK, Pfizer and Moderna have developed RSV shots approved by the U.S. Food and Drug Administration, with GSK's Arexvy responsible for the majority of U.S. RSV vaccine sales.

Reuters 21 days ago

GSK

PFE
Spirits, Swiss Watches, Sneakers: Global Stock-Market Winners and Losers from Tariffs

Here are some notable moves across sectors in global markets, following President Trump’s “Liberation Day” tariffs. Some investors turned to drink: Scotch producer Diageo and Aperol maker Campari were among the few risers in Europe. This is mostly about their imports from Mexico and Canada, brokers say, after the White House kept duty-free access to the U.S. for USMCA-compliant products.

The Wall Street Journal 21 days ago

NKE

AZN

AZNCF
0.00%
How Trump's tariffs will impact your finances and the UK economy

Keir Starmer has admitted the US president's trade war will hurt the UK economy.

Yahoo Finance UK 21 days ago

LVMHF

LVMUY

GBPEUR=X
Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report?

Glaxo (GSK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks 22 days ago

GSK
Is GSK plc (GSK) the Most Undervalued Healthcare Stock to Buy According to Analysts?

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other most undervalued healthcare stocks to buy according to analysts. Rising Healthcare Costs and the Impact of Tariffs on US-China Trade in […]

Insider Monkey 23 days ago

GSK
Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out

Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger drugmakers, such as GSK, also retreated.

The Wall Street Journal 24 days ago

MRNA

SRPT

PFE
Is GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds?

We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ADR stocks. American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American investors […]

Insider Monkey 27 days ago

GSK
China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market

Boosted by partnerships with Big Pharma and a push into China, Veeva continues to battle to break out in troubled market.

Investor's Business Daily 27 days ago

GLAXF
+6.58%
GSK

VEEV

Performance Overview

Return	GLAXF	FTSE 100 (^FTSE)
YTD	+10.54%	+2.87%
1-Year	-2.76%	+4.56%
3-Year	-6.02%	+11.78%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

GSK plc (GLAXF)

Shingles Vaccine Appears to Lower Dementia Risk

Why vaccine makers aren't worried about Trump administration cuts

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years

UK Becomes First Country To Authorize Blenrep In Two Combo Regimens

Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease

AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices

GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices

GSK (LSE:GSK) Sees 6% Share Price Decline Over The Last Quarter

GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025

Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca

New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops

GSK resolves patent lawsuit against Pfizer over RSV vaccines

Spirits, Swiss Watches, Sneakers: Global Stock-Market Winners and Losers from Tariffs

How Trump's tariffs will impact your finances and the UK economy

Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report?

Is GSK plc (GSK) the Most Undervalued Healthcare Stock to Buy According to Analysts?

Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out

Is GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds?

China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market

Performance Overview